CD44 and head and neck squamous cell carcinoma: To investigate possible new targets for radioimmunotherapy in combination with HSP90 inhibition we studied the cell surface protein CD44v6, an oncogenic isoform of the hyaluronan binding molecule CD44 frequently overexpressed in HNSCC [15, 23].